MICHAEL JAMES OVERMAN to Myeloid-Derived Suppressor Cells
This is a "connection" page, showing publications MICHAEL JAMES OVERMAN has written about Myeloid-Derived Suppressor Cells.
Connection Strength
0.200
-
Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancer. J Immunother Cancer. 2020 02; 8(1).
Score: 0.162
-
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer. Cancer Cell. 2019 04 15; 35(4):559-572.e7.
Score: 0.038